In this article, we describe the role of bone-targeted therapies, specifically for managing early breast cancer, by reviewing their bone-specific and cancer-specific benefits.
Kathleen I. Pritchard, MD, FRCPC
Advertisement
Articles by Kathleen I. Pritchard, MD, FRCPC
Bisphosphonates have played an important role in the treatment of breast cancer, mainly in patients with bone metastasis, by reducing the risk of fracture, spinal cord compression, and hypercalcemia.
Advertisement
Latest Updated Articles
- The Role of Bisphosphonates in Early- and Advanced-Stage Breast Cancer: Have We Finally Optimized Care?
Published: January 15th 2015 | Updated:
Bone-Targeted Therapy in Early Breast CancerPublished: November 15th 2018 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
CRT Does Not Improve RFS/OS, Confers High-Grade Toxicity in Cervical Cancer
2
Progress in the Treatment of Advanced-Stage Classical Hodgkin Lymphoma in the PET-Adapted Era
3
ctDNA Status May Determine Adjuvant Immunotherapy Benefit in MIBC
4
Frontline Tislelizumab Combo Improves Long-Term Survival in ES-SCLC
5
